24. Aliskiren in patients failing to achieve blood pressure targets with angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
- Hawkins, Elizabeth B. Pharm.D.
- Ling, Hua Pharm.D.
- Burns, Tammy L. Pharm.D.
- Mooss, Aryan M.D.
- Hilleman, Daniel E. Pharm.D., FCCP
Pharmacotherapy: The Journal Of Human Pharmacology & Drug Therapy 32(10):p e184, October 2012.

Copyright © 2012 John Wiley & Sons, Inc.